iiinova — where your digital self keeps evolving

Krzysztof Potempa @braincures.bsky.social · 04/09/2026

🧵 Organizations should not be allowed to protect their image by shutting down a complaint too quickly. Investigations need to be genuinely independent, not conducted by single individuals from private employment-law firms in the pay of the institution @nature.com www.linkedin.com/pulse/sanger...

000

Krzysztof Potempa @braincures.bsky.social · 28/06/2026

With great power comes great responsibility: how scientific supervisors shape the wellbeing of early-career researchers by Xabier Simón Martínez de Goñi @martinezgonixs.bsky.social, Agustín Javier Marín Peña, Mario Corrochano Monsalve, Adrián Bozal-Leorri @amoadrian-bl.bsky.social

010

Krzysztof Potempa @braincures.bsky.social · 24/06/2026

🧵 #BIO2026 What should be done about the pay gap between the 25 highest-paid CEOs in biopharma with over $25 million paydays and their employees sitting on about 250-fold lower salaries? Of note, the typical worker in pharma/biotech made $116,648 in 2025 www.linkedin.com/posts/krzysz...

000

Krzysztof Potempa @braincures.bsky.social · 28/04/2026

🧵 Ten lessons from a decade of scientific translation at @crick.ac.uk by Stephen Mayhew, Dave Allen and David Roblin. Paywall link @natmed.nature.com www.nature.com/articles/s41.... See www.linkedin.com/pulse/franci... to learn more about The Francis Crick Institute

100

Krzysztof Potempa @braincures.bsky.social · 20/04/2026

The BRAINCURES Discovery Engine prioritization of 229 Parkinson targets identifies 34 BDE targets, 11 BDE hubs, 2 BDE masters. Additionally, 83 of 229 community-led targets have hub protein properties. See www.michaeljfox.org/targets-ther... to explore Michael J Fox Foundation’s Targets to Therapies

000

Krzysztof Potempa @braincures.bsky.social · 19/04/2026

BRAINCURES virtual phenotypic screening to accelerate the Drug Prioritization of Disease Modification Trials in Parkinson’s: The International Linked Clinical Trials Initiative-iLCT by Richard Wyse @cureparkinsons.org.uk,Tom Isaacs, Roger Barker, … and Patrik Brundin www.linkedin.com/posts/brainc...

000

Krzysztof Potempa @braincures.bsky.social · 10/03/2026

George Kassiotis is a Group Leader and head of the laboratory of Retroviral Immunology at @crick.ac.uk institute, London, UK. The Crick protected this @imperialcollegeldn.bsky.social professor and recipient of a new investigator award from @wellcometrust.bsky.social www.linkedin.com/pulse/ula-sc...

000

Krzysztof Potempa @braincures.bsky.social · 05/03/2026

🧵Why has the MeToo revolution spared Woody Allen? How did President Donald Trump and Bill Clinton-pal Jeffrey Epstein escape me too? After #MeToo, do we need women-only colleges more than ever? Are a few “toxic” anti-male women derailing the validity of MeToo? #SDG16 www.linkedin.com/posts/krzysz...

000

Krzysztof Potempa @braincures.bsky.social · 26/02/2026

🧵Wellcome Trust's Track Record of ReImagining #ResearchCulture. The fact that @wellcometrust.bsky.social applied sanctions in only 7 (18%) of 39 cases of bullying or harassment relating to organizations it had funded from May 2018 to September 2021 speaks for itself. www.linkedin.com/posts/krzysz...

000

Krzysztof Potempa @braincures.bsky.social · 17/02/2026

🧵Intriguing people redactions and highlights from 138 Epstein files associated with Alzheimer’s disease. People not redacted include Paola Leone, Barbro Ehnbom, Bengt Winblad, Judith Miklossy, Niranjan Bose, Ronald Lauder, Bruce Moskowitz, Bill Gates, Larry Cohen www.linkedin.com/posts/krzysz...

101

Krzysztof Potempa @braincures.bsky.social · 15/01/2026

🧵 Most recently, the @nobelprize.org winning scientist Sir Paul Nurse presided over poor research culture at the @crick.ac.uk. When challenged about it he denied having any knowledge of whistleblowing issues around bullying, discrimination, harassment & victimisation www.linkedin.com/pulse/ula-sc...

020

Krzysztof Potempa @braincures.bsky.social · 05/01/2026

🧵Can we bring more cures for brain diseases by 2030? Two Steps Forward, One Step Back: The Long Road to Success in Central Nervous System (CNS); Trends in Neuroscience Drug Discovery and Development; Pharma Ins & Outs Neurology provide some excellent insights. See www.linkedin.com/posts/brainc...

000

Krzysztof Potempa @braincures.bsky.social · 31/12/2025

2025–Many high-flying AI companies struggled while a few techbios turbocharged with millions. lnkd.in/dVaGzWw3 outlines partnerships between AI biotech startups & pharma. Isn’t it interesting that @insitro.bsky.social’s CEO is the only female among 8 male techbio leaders making headlines this year?

030

Krzysztof Potempa @braincures.bsky.social · 19/12/2025

Congratulations to science sleuth @sholtodavid.bsky.social for his successful whistleblowing on poor research integrity matters at @danafarber.bsky.social. The scientific misconduct whistleblower wins $2.63 million from major cancer institute in $15M settlement. See www.linkedin.com/posts/krzysz...

120

Krzysztof Potempa @braincures.bsky.social · 03/10/2025

#ResearchCulture Chronic silencing is a critical barrier to breaking the cycle of bullying in academia and industry by Alison Vogelaar and Morteza Mahmoudi. See www.linkedin.com/posts/krzysz... for further Academic Parity papers

001

Krzysztof Potempa @braincures.bsky.social · 21/02/2025

🧵 Elon Musk and the developing The Royal Society saga highlights: 1) An open letter to the President of the Royal Society – time to stand up for your values by Steve Curry 2) Dorothy Bishop @deevybee.bsky.social's blog on why she resigned from the Royal Society www.linkedin.com/posts/krzysz...

000